-
The genomic landscape of cutaneous squamous cell carcinoma from immunosuppressed and immunocompetent patients reveals common drivers and a novel mutational signature associated with chronic azathioprine exposure
Study
EGAS00001002612
-
Whole-exome sequencing of ovarian clear cell carcinoma in clinical outliers
Study
EGAS00001004248
-
We performed whole-exome sequencing of 20 samples (10 actinic keratosis and 10 cutaneous squamous cell carcinoma) to investigate a potential relationship between DNA methylation-based subtypes and genetic mutation patterns (Rodriguez-Paredes et al., Nat Commun 2017)
Study
EGAS00001002670
-
Alternative splicing isoforms in patient-derived hepatocellular carcinoma cells
Study
EGAS00001002697
-
Gut microbiome modulates response to anti PD1 immunotherapy in metastatic melanoma patients
Study
EGAS00001002698
-
Whole exome sequencing of cell-free DNA reveals temporo-spatial heterogeneity and identifies treatment-resistant clones in neuroblastoma
Study
EGAS00001002705
-
Sequencing-based counting and size profiling of plasma Epstein-Barr virus DNA enhance population screening of nasopharyngeal carcinoma.
Study
EGAS00001002707
-
Aggressive genomic features in clinicallyindolent primary HHV8-negative effusion-based lymphoma
Study
EGAS00001002743
-
Defective T-cell expansion in RASGRP1 deficiency
Study
EGAS00001002753
-
Aberrant ERBB4-SRC Signaling as a Hallmark of Group 4 Medulloblastoma Revealed by Integrative Phosphoproteomic Profiling
Study
EGAS00001002757